RecruitingPhase 2NCT03290534

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Sponsor

CivaTech Oncology

Enrollment

40 participants

Start Date

Mar 13, 2019

Study Type

INTERVENTIONAL

Conditions

Lung Cancer Lung Cancer Stage I Lung Cancer Stage II

Summary

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a permanently implanted, flexible radiation device called CivaSheet during lung cancer surgery, where it is placed over the tumor site to deliver low-dose radiation continuously from inside the body after the tumor has been removed. **You may be eligible if...** - You have a suspected or confirmed non-small cell lung cancer (NSCLC) in the upper portion of the left or right lung - Your tumor is no larger than 7 cm - Your cancer is at an early to intermediate stage (Stage I or II) - You have not had another invasive cancer within the past 5 years (except non-melanoma skin cancer or in-situ cancer) - You are not pregnant or nursing **You may NOT be eligible if...** - There are no additional specific exclusion criteria listed beyond the requirements above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.